Basit öğe kaydını göster

A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study

dc.contributor.authorManns, M. P.
dc.contributor.authorFehmi, T.
dc.contributor.authorWoebse, M.
dc.contributor.authorWedemeyer, H.
dc.contributor.authorHardtke, S.
dc.contributor.authorWranke, A.
dc.contributor.authorYurdaydin, C.
dc.contributor.authorHeidrich, B.
dc.contributor.authorKalliopi, Z.
dc.contributor.authorYalcin, K.
dc.contributor.authorAkarca, U.
dc.contributor.authorLammert, F.
dc.contributor.authorHaeussinger, D.
dc.contributor.authorMueller, T.
dc.date.accessioned2021-03-05T08:20:20Z
dc.date.available2021-03-05T08:20:20Z
dc.identifier.citationWranke A., Yurdaydin C., Heidrich B., Kalliopi Z., Yalcin K., Fehmi T., Akarca U., Lammert F., Haeussinger D., Mueller T., et al., "A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study", International Liver Congress (ILC), Paris, Fransa, 11 - 15 Nisan 2018, cilt.68
dc.identifier.othervv_1032021
dc.identifier.otherav_985d4c92-aa3d-42e4-87df-00a12253a860
dc.identifier.urihttp://hdl.handle.net/20.500.12627/102530
dc.identifier.urihttps://doi.org/10.1016/s0168-8278(18)31261-3
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleA virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study
dc.typeBildiri
dc.contributor.departmentHannover Medical School , ,
dc.identifier.volume68
dc.contributor.firstauthorID153263


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster